Clinical trial
Serum Metabolomics Study of Polycystic Ovary Syndrome Based on Liquid Chromatography-Mass Spectrometry
NCT03618342 is registered in ClinicalTrials.gov with Heilongjiang University of Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serum Metabolomics Study of Polycystic Ovary Syndrome Based on Liquid Chromatography-Mass Spectrometry
- Lead sponsor
- Heilongjiang University of Chinese Medicine
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 2, 2018
- Completion date
- March 31, 2020
- Enrollment
- 1,272 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.